Skip to main content
TipRanks
Go Ultimate75% OFF

Zealand Pharma (ZLDPF) Stock Forecast & Price Target

201 Followers
See the Price Targets and Ratings of:

ZLDPF Analyst Ratings

Moderate Buy
2Ratings
1Buy1Hold0Sell
Based on 2 analysts giving stock ratings to Zealand Pharma in the past 3 months

ZLDPF Stock 12 Month Forecast

$57.15▲(60.16% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Zealand Pharma in the last 3 months. The average price target is $57.15 with a high forecast of $65.00 and a low forecast of $49.31. The average price target represents a 60.16% change from the last price of $35.68.
Highest Price Target$65.00Average Price Target$57.15Lowest Price Target$49.31

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for ZLDPF
Price TargetArticle
Barclays$63.50→$49.31hold38.18%UpsideDowngraded09/08/26
J.P. Morgan$68.73→$65.00buy82.15%UpsideReiterated08/25/26
Jefferies$75.46→$47.82hold33.99%UpsideDowngraded07/13/26
Berenberg Bank$123.27→$44.83hold25.62%UpsideDowngraded06/16/26
Deutsche Bank $41.09→$44.83hold25.62%UpsideReiterated06/04/26
UBS$109.08buy205.67%UpsideReiterated05/08/26
SEB Enskilda$56.78→$70.98buy98.89%UpsideUpgraded04/29/26
Nordea Markets―hold―Downgraded03/06/26
Cantor Fitzgerald―hold―Downgraded03/06/26
William Blair―hold―Downgraded03/06/26
Exane BNP Paribas$41.09hold15.15%UpsideDowngraded03/06/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PLSEPulse Biosciences
SLDBSolid Biosciences
RZLTRezolute
IMUXImmunic
MDWDMediwound

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Zealand Pharma

3 Months
Thomas Bowers
Thomas BowersSEB Enskilda
Success Rate1/2 ratings generated profit
50%
Average Return
+7.05%

Copying Thomas Bowers's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +7.05% per trade.

1 Year
Thomas Bowers
Thomas BowersSEB Enskilda
Success Rate1/2 ratings generated profit
50%
Average Return
-6.00%

Copying Thomas Bowers's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -6.00% per trade.

2 Years
Thomas Bowers
Thomas BowersSEB Enskilda
Success Rate1/2 ratings generated profit
50%
Average Return
-6.00%

Copying Thomas Bowers's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -6.00% per trade.

ZLDPF Analyst Recommendation Trends

05101520Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for ZLDPF
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy10000
Buy11110
Hold33211
Sell00000
Strong Sell00000
total54321

In the current month, ZLDPF has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. ZLDPF average Analyst price target in the past 3 months is 57.15.

ZLDPF Financial Forecast

$-4$-0.75$2.5$5.75$9Q1 2026Q3 2026Q4 2026
High$-1.50
Consensus$-2.09
Low$-2.89

ZLDPF Earnings Forecast

Next quarter’s earnings estimate for ZLDPF is -$2.09 with a range of -$2.89 to -$1.50. The previous quarter’s EPS was -$0.12. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$-1$165.6M$331.1M$496.7M$662.2MQ1 2026Q3 2026Q4 2026
High$9.79M
Consensus$2.55M
Low$0.00

ZLDPF Sales Forecast

Next quarter’s sales forecast for ZLDPF is $2.55M with a range of $0 to $9.79M. The previous quarter’s sales results were $589.84K. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

ZLDPF Stock Forecast FAQ

What is ZLDPF’s average 12-month price target, according to analysts?
Based on analyst ratings, Zealand Pharma’s 12-month average price target is $57.15.
What is ZLDPF’s upside potential, based on the analysts’ average price target?
Zealand Pharma has 60.16% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ZLDPF a Buy, Sell or Hold?
Zealand Pharma has a consensus rating of Moderate Buy which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.
What is Zealand Pharma’s price target?
The average price target for Zealand Pharma is $57.15. This is based on 2 12-month price targets, issued in the past 3 months. The highest analyst price target is $65.00, the lowest forecast is $49.31. The average price target represents a 60.16% increase from the current price of $35.685.
What do analysts say about Zealand Pharma?
Zealand Pharma’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of ZLDPF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.